Business Context and Reporting Period
Relay Therapeutics, Inc. (RLAY) filed a Form 8-K on May 26, 2021, reporting the entry into a material definitive agreement. The company, an emerging growth company incorporated in Delaware, operates from its headquarters at 399 Binney Street, Cambridge, Massachusetts.
Key Financial Metrics and Obligations
This filing details a new lease agreement rather than periodic financial performance metrics such as revenue or cash flow. Key financial terms of the new agreement include:
- Lease Term: 10 years following the Rent Commencement Date.
- Base Rent: $110.00 per rentable square foot per year in the first year.
- First Year Cost: Approximately $4.6 million in total base rent.
- Rent Escalation: Scheduled annual increases of 3%.
- Tenant Improvements: Landlord contribution of $6.2 million toward construction and improvements.
- Space: Approximately 41,474 square feet of laboratory and office space.
Material Changes Versus Prior Period
The filing represents a material expansion of the company's physical footprint. The new lease at 60 Hampshire Street will supplement the company's existing headquarters at 399 Binney Street, where it currently leases approximately 46,631 square feet under an agreement running through April 2029.
Outlook, Risks, and Contingencies
The commencement of rent payments is contingent upon the completion of tenant improvements or the tender of possession by the landlord, whichever occurs later. The filing notes that the description of lease terms is qualified by reference to the full text of the Lease, which will be filed in the Quarterly Report on Form 10-Q for the period ended June 30, 2021. No specific risks or contingencies beyond the standard lease obligations were detailed in this excerpt.
Investor Verification Checklist
- Verify the exact "Rent Commencement Date" once construction is complete to determine when cash outflows begin.
- Review the full Lease agreement in the upcoming Form 10-Q for details on operating expenses, taxes, and renewal options.
- Assess the impact of the $4.6 million annual rent obligation on the company's cash burn rate and liquidity.
- Confirm the status of the $6.2 million tenant improvement contribution and any conditions attached to it.